Persistent lymphopenia after dimethyl fumarate and fingolimod treatment

被引：0
|
作者：
Hernandez, I. [1 ]
Mulero, P. [1 ]
Neri, M. J. [1 ]
Redondo, N. [1 ]
Abad, E. [2 ]
Tellez, N. [1 ]
机构：
[1] Hosp Clin Valladolid, Neurol, Valladolid, Spain
[2] Hosp Clin Valladolid, Pharm, Valladolid, Spain
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P775
引用
收藏
页码：644 / 645
页数：2
相关论文
共 50 条
  • [21] Stability of longitudinal DTI metrics in MS with treatment of injectables, fingolimod and dimethyl fumarate
    Alshehri, Abdulaziz
    Al-iedani, Oun
    Koussis, Nikitas
    Khormi, Ibrahim
    Lea, Rodney
    Lechner-Scott, Jeannette
    Ramadan, Saadallah
    NEURORADIOLOGY JOURNAL, 2023, 36 (04): : 388 - 396
  • [22] Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: one year experience
    Vollmer, B. L.
    Nair, K.
    Sillau, S. H.
    Strobel, M.
    Robinson, L.
    Corboy, J.
    Vollmer, T.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 536 - 536
  • [23] Stability of longitudinal DTI metrics in MS with treatment of injectables, fingolimod and dimethyl fumarate
    Alshehri, A.
    Al-Iedani, O.
    Koussis, N.
    Khormi, I.
    Lea, R.
    Lechner-Scott, J.
    Ramadan, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 376 - 376
  • [24] Dimethyl fumarate: risk of PML associated with mild lymphopenia
    Reactions Weekly, 2021, 1839 (1) : 4 - 4
  • [25] Immunological Predictors of Dimethyl Fumarate-Induced Lymphopenia
    Diebold, Martin
    Galli, Edoardo
    Kopf, Andreas
    Sanderson, Nicholas
    Callegari, Ilaria
    Ingelfinger, Florian
    Nunez, Nicolas Gonzalo
    Benkert, Pascal
    Kappos, Ludwig
    Kuhle, Jens
    Becher, Burkhard
    Claassen, Manfred
    Derfuss, Tobias
    ANNALS OF NEUROLOGY, 2022, 91 (05) : 676 - 681
  • [26] Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population
    Boffa, Giacomo
    Bruschi, Nicolo
    Cellerino, Maria
    Lapucci, Caterina
    Novi, Giovanni
    Sbragia, Elvira
    Capello, Elisabetta
    Uccelli, Antonio
    Inglese, Matilde
    CNS DRUGS, 2020, 34 (04) : 425 - 432
  • [27] Fingolimod and dimethyl-fumarate derived lymphopenia is not associated with short-term treatment response and risk of infections in a real-life MS population
    Bruschi, N.
    Boffa, G.
    Cellerino, M.
    Lapucci, C.
    Novi, G.
    Sbragia, E.
    Capello, E.
    Uccelli, A.
    Inglese, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 201 - 201
  • [28] Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population
    Giacomo Boffa
    Nicolò Bruschi
    Maria Cellerino
    Caterina Lapucci
    Giovanni Novi
    Elvira Sbragia
    Elisabetta Capello
    Antonio Uccelli
    Matilde Inglese
    CNS Drugs, 2020, 34 : 425 - 432
  • [29] Factors associated with dimethyl fumarate-induced lymphopenia
    Sainz de la Maza, Susana
    Medina, Silvia
    Villarrubia, Noelia
    Costa-Frossard, Lucienne
    Monreal, Enric
    Tejeda-Velarde, Amalia
    Rodriguez-Martin, Eulalia
    Roldan, Ernesto
    Alvarez-Cermeno, Jose C.
    Villar, Luisa M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 398 : 4 - 8
  • [30] Dimethyl fumarate/fingolimod/natalizumabLymphopenia: 5 case reports
    Reactions Weekly, 2021, 1876 (1) : 126 - 126
12345